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ABSTRACT
Chicken whole-genome gene expression arrays were used to analyze the host response to infection by infectious bursal disease
virus (IBDV). Spleen and bursal tissue were examined from control and infected birds at 2, 3, and 4 days postinfection from two
lines that differ in their resistance to IBDV infection. The host response was evaluated over this period, and differences between
susceptible and resistant chicken lines were examined. Antiviral genes, including IFNA, IFNG,MX1, IFITM1, IFITM3, and
IFITM5, were upregulated in response to infection. Evaluation of this gene expression data allowed us to predict several genes as
candidates for involvement in resistance to IBDV.
IMPORTANCE
Infectious bursal disease (IBD) is of economic importance to the poultry industry and thus is also important for food security.
Vaccines are available, but field strains of the virus are of increasing virulence. There is thus an urgent need to explore new con-
trol solutions, one of which would be to breed birds with greater resistance to IBD. This goal is perhaps uniquely achievable with
poultry, of all farm animal species, since the genetics of 85% of the 60 billion chickens produced worldwide each year is under
the control of essentially two breeding companies. In a comprehensive study, we attempt here to identify global transcriptomic
differences in the target organ of the virus between chicken lines that differ in resistance and to predict candidate resistance
genes.
Infectious bursal disease virus (IBDV) is a highly contagious vi-rus with a bisegmented double-stranded RNA (dsRNA) genome
(belonging to the family Birnaviridae) which causes immunosup-
pression in chickens (1). Segment A contains two overlapping
open reading frames, the larger of which encodes viral proteins
VP2, VP3 (both structural capsid proteins), and VP4 (a viral pro-
tease). The smaller open reading frame encodes the nonstructural
protein VP5. Segment B encodes VP1 which is a multifunctional
polymerase. There are two known serotypes: serotype I viruses
cause a range of disease severity in chickens and are further clas-
sified into classic, variant, and highly virulent strains, and serotype
II viruses are nonpathogenic. Although largely controlled by vac-
cination, new virulent strains of the virus mean that infectious
bursal disease (IBD; also known as “Gumboro” disease) still re-
main a threat to the poultry industry. The virus infects dividing
IgM B lymphocytes and the main site of viral replication is the
bursa of Fabricius, where B cells are produced (2, 3). IBDV can
also infect macrophages (3–5).
Infection is spread orally via contaminated feed and water (6).
IBDVaffects young birds, with the disease usually being diagnosed
in 3- to 6-week-old birds. Younger birds do not show clinical signs
but are immunosuppressed (7, 8). Symptoms include anorexia,
depression, diarrhea, ruffled feathers, immunosuppression, and
bursal lesions. Death is often due to dehydration, which leads to
kidney lesions (9). The disease peaks between 2 to 5 days postin-
fection (dpi) and is practically cleared by day 7 (10). During this
acute phase, bursal follicles are depleted of B cells, and the bursa
becomes atrophic. Abundant viral antigen can be detected in the
bursal follicles and other lymphoid organs such as the cecal tonsils
and spleen. CD4 andCD8T cells accumulate around the site of
virus replication (6).Mortality is variable and tends to affect layers
more than broilers but can be up to 100% with very virulent
strains of the disease. Even if birds survive, the resulting immuno-
suppression and effect on egg production in layer birds is signifi-
cant (11).
Although disease is currently controlled by vaccination, alter-
native control measures are being explored, including breeding
for enhanced genetic resistance. Involvement of the major histo-
compatibility complex (MHC) in resistance to IBDV has been a
topic for debate, but it does appear to have a role (12). Two spe-
cific-pathogen-free lines of chickens held at The Pirbright Insti-
tute (previously known as the Institute for Animal Health), a
Brown Leghorn line and the White Leghorn line 61, were previ-
ously shown to be susceptible and resistant, respectively, to IBD
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(13). Differences in IBDV viral loads, measured by quantitative
reverse transcription-PCR (qRT-PCR), in the bursae of infected
birds of these two lines were evident from as early as 1 dpi (14). In
the present study, we carry out a comprehensive gene expression
study, comparing the response to infection in the two lines at 2, 3,
and 4 dpi, with the hypothesis that genes underlying at least some
of the resistance mechanisms will be involved at this early, innate
stage of the immune response.
MATERIALS AND METHODS
Ethics statement. All animal work was conducted according to United
Kingdom Home Office guidelines.
Experimental animals. Three-week-old birds from each line (61 and
Brown Leghorn [Brl]) were separated into two experimental rooms, with
ad libitum access to food and water. In one room, 54 birds were mock
infected intranasally with 100 l of phosphate-buffered saline (PBS; 27
birds from each line). In the other room, 54 birds were infected intrana-
sally (27 birds from each line) with 101.3 50% embryonic infectious doses
(EID50) of the classical virulent IBDV strain F52/70 in 100 l of PBS. The
birds were monitored for clinical signs for up to 4 dpi and killed at 2, 3, or
4 dpi (nine individuals at each time point). Spleens and bursae were col-
lected from all birds for qRT-PCR analysis for virus and host genes, for
microarray analysis, and for bursal damage scores by immunohistochem-
istry. Blood samples were also taken from each bird for DNA isolation.
Bursal damage scoring. Segments of bursal tissue were fixed in form-
aldehyde-saline (pH 7.6) before routine histological processing and stain-
ingwith hematoxylin and eosin. The degree of bursal damagewas assessed
using the histological scoring system (scored in the range 0 to 5, with 5
indicating the greatest level of damage) described by Muskett et al. (15),
with each section being scored blindly by two separate individuals.
RNA preparation. Tissue samples (30 mg) were stabilized in
RNAlater (Ambion/Life Technologies, Paisley, United Kingdom) and
disrupted using a bead mill (Retsch MM 300; Retsch, Haan, Germany)
at 20 Hz for 4 min. Total RNA was prepared using an RNeasy kit
(Qiagen, Crawley, United Kingdom) extraction method according to
the manufacturer’s protocol. Samples were resuspended in a final vol-
ume of 50 l of RNase-free water. Concentrations of the samples were
calculated by measuring the optical density at 260 nm (OD260) and the
OD280 on a spectrophotometer (NanoDrop; Thermo Scientific, Pais-
ley, United Kingdom). The quality of the RNA was checked on a bio-
analyzer (Agilent Technologies, South Queensferry, United King-
dom). An RNA integrity number (RIN) of 8 proved the integrity of
the RNA.
Microarray hybridization. Biotinylated fragmented cRNA was hy-
bridized to the Affymetrix chicken genome array (Affymetrix, Santa
Clara, CA). This array contains comprehensive coverage of 32,773 tran-
scripts corresponding to 28,000 chicken genes. It also contains 689
probe sets for 684 transcripts from 17 avian viruses, including IBDV. For
each experimental group (infected/control in two tissues at three time
points in two lines), three biological replicates (three pools of RNA from
three birds) were hybridized. Thus, 72 arrays were used in total. Hybrid-
ization was performed at 45°C for 16 h in a hybridization oven with con-
stant rotation (60 rpm). Themicroarrays were then automatically washed
and stained with streptavidin-phycoerythrin conjugate (SAPE; Invitro-
gen) in a Genechip fluidics station (Affymetrix). Fluorescence intensities
were scanned with a GeneArray Scanner 3000 (Affymetrix). The scanned
images were inspected and analyzed using established quality control
measures. Array data have been submitted to Array Express (http://www
.ebi.ac.uk/arrayexpress/) under the accession number E-TABM-1129.
Statistical analysis. Gene expression data generated from the
GeneChip Operating Software (GCOS) were normalized using the PLIER
(probe logarithmic intensity error) method (16) within the Affymetrix
expression console software package. These normalized data were then
analyzed using the limma and FARMS (17) packages within R in Biocon-
ductor (18). Probes with a false discovery rate (FDR) of0.05 and a fold
change of2 were deemed to be significant.
Analysis of differentially expressed genes. Gene ontogoly (GO)
terms associated with genes differentially expressed (DE) during the host
response were analyzed using EasyGO (http://bioinformatics.cau.edu.cn
/easygo/). To determine which biological pathways are involved in the
responses to viral infection, Pathway Express (http://vortex.cs.wayne.edu
/projects.htm) was used. Genes differentially expressed during the host
response (FDR  0.05) were analyzed against a reference background
consisting of all genes expressed in the experiment. Factors considered by
Pathway Express include themagnitude of a gene’s expression change and
its position and interactions in any given pathway, thus including an “im-
pact factor” when calculating statistically significant pathways. Anything
with a P value of0.25 is deemed significant when using this software.
Genes were clustered by similar expression pattern and analyzed for
enriched GO terms and transcription factor binding sites (TFBS) using
Expander (v5.2) (http://acgt.cs.tau.ac.il/expander/expander.html). Nor-
malized expression data from control samples were compared to infected
samples to examine the host response to IBDV infection. Enrichment
analysis of particular GO terms or TFBS within clusters was done using
the TANGO and PRIMA functions, respectively, within the Expander
package.Use of the Ingenuity PathwayAnalysis (IPA) program (Ingenuity
Systems) revealed which canonical pathways and physiological functions
were affected by IBDV infection in the host (Benjamini-Hochberg multi-
ple testing correction; FDR 0.05).
Viral quantification and specific gene expression analysis by quan-
titative real-time PCR.TaqMan real-time qRT-PCRwas used to quantify
viral RNA levels and for confirmation of the microarray results for the
mRNA levels of selected genes. Primers (Sigma) and probe (PE Applied
Biosystems,Warrington,UnitedKingdom) (Table 1) were designed using
Primer Express (PE Applied Biosystems). Briefly, the assays were per-
formed using 2 l of total RNA and the TaqMan FAST Universal PCR
master mix and one-step RT-PCR Mastermix reagents (PE Applied Bio-
systems) in a 10-l reaction. Amplification and detection of specific prod-
ucts were performed using the Applied Biosystems 7500 Fast real-time
PCR system with the following cycle profile: one cycle at 48°C for 30 min
and 95°C for 20 s, followed by 40 cycles at 95°C for 3 s and 60°C for 30 s.
The data are expressed in terms of the cycle threshold (CT) value, normal-
ized for each sample using theCT value of 28S rRNA product for the same
sample, as described previously (19–21). The final results are shown as
40-CT using the normalized value, or as fold change from uninfected
controls.
RESULTS
Assessment of IBDV viral load in susceptible and resistant
chicken lines. After challenge of the two inbred lines, TaqMan
analysis was used to measure viral load in bursal samples from
control and infected birds from both lines. It became immediately
obvious on analyzing the viral load data that the respective phe-
notype of the two lines (BrL susceptible and line 61 resistant) had
reversed since the lines were last studied in previous decades (13,
14). In repeated experiments, the line 61 birds were susceptible
and the BrL birds were highly resistant, with only the odd BrL bird
showing detectable viral load in the bursa postchallenge (Fig. 1A).
In terms of bursal damage, all control birds had no signs of bursal
damage, whereas all infected birds had some bursal damage (Fig.
1B). At 3 and 4 dpi, high bursal viral loads in the line 61 birds
correlatedwith high bursal damage scores, whereas bursal damage
scores in infected BrL birds remained low (Fig. 2).
The viral response upon infection. As well as representing
more than 28,000 chicken genes, the Affymetrix whole-genome
array also contains probe sets for avian viral genes, including
probes covering the IBD viral genes, i.e., VP1, VP2-3-4, and VP5,
thus allowing the simultaneous analysis of changes in viral gene
Smith et al.
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TABLE 1 Primers used in qRT-PCR analysis of IBDV candidate genes
Primer Sequence (5=-3=) Size (bp) Tm (°C) %GC
SRFBP1_forward CACTGCAAGTGAGCGAGCTATT 22 55 50
SRFBP1_reverse GCAGCTTTAAGTTCAGCAATTTTG 24 52 38
SRFBP1_probe CAAGACTTGCAACACACCCCCTTCTGA 27 61 52
XRCC3_forward GCAGACCTGGACACCTTCCA 20 56 60
XRCC3_reverse CGCACCATGCCTCTTGTG 18 53 61
XRCC3_probe ACTGCATTACGAAGAGGCTGTCCCTGC 27 63 56
TNFRSF1B_forward CGAGGAAAGGCTTAAGAAATGTTG 24 54 42
TNFRSF1B_reverse CGCTGTGACTGCAGCTCTCT 20 56 60
TNFRSF1B_probe AGCAAATGCCCTCCAGGTCAGCG 23 60 61
CARD9_forward AACGCAAAGCAGGTGTTCTTC 21 52 48
CARD9_reverse TCTCCATGAATGCCTCAAAGC 21 52 48
CARD9_probe ACATTCTACAGCGAACAGGGCGCAA 25 59 52
BLVRA_forward ACCGTTCATTTTCAGACTGCAA 22 51 41
BLVRA_reverse CCACTGGTGAAACAGAAATTGATT 24 52 38
BLVRA_probe CAAGAAGCCTCTCACTTGGATCGAAGAACG 30 63 50
AICDA_forward GCGCTGGGCCAAAGG 15 50 73
AICDA_reverse CAACCCATCTTGTTACGCAGGTA 23 55 48
AICDA_probe ACCTACCTCTGTTATGTTGTGAAGCGCCG 29 63 52
MYBL1_forward GGCTGCTCAGGAAAAAAAGTATG 23 53 43
MYBL1_reverse TTCCCTAATGTCTTCCTCCAAGAA 24 54 42
MYBL1_probe CCCTCTCAAACTTACGTCACAACCACTTGC 30 63 50
TLR2B_forward GAGCACCAGGGAATGGTTTC 20 54 55
TLR2B_reverse GCTGTCTGGCTGAGGCTTTT 20 54 55
TLR2B_probe CACAGAGCCAGCTTCACGTAACCAAAGAA 29 62 48
B6.3_forward ACTGGAAGTATTTGAGCCGATCA 23 54 43
B6.3_reverse CGTTGCAAGTTAAGTCTGCAGTTC 24 56 46
B6.3_probe TGATGCCCGGTGCTTCCCCA 20 58 65
IL13RA2_forward GCTGCCTGGGCGTCTGT 17 54 71
IL13RA2_reverse CTCCGATTTGCTCTGGAGATG 21 54 52
IL13RA2_probe CCACCCAAGTGGAGACCGCTTTCA 24 61 58
CCL19_forward CGGATAGTGCAGGACTACAGGAT 23 57 52
CCL19_reverse GAGCCGCTTGCCCTTTG 17 52 65
CCL19_probe ACATCCCTGCCACCGTGTTCATCA 24 60 54
IFNB_forward CCTCCAACACCTCTTCAACATG 22 55 50
IFNB_reverse TGGCGTGTGCGGTCAAT 17 50 59
IFNB_probe TTAGCAGCCCACACACTCCAAAACACTG 28 61 50
chCCLi3_forward TGCACCACTTACATAACACACAAGAT 26 55 38
chCCLi3_reverse TGAAGATGATGGCAGGCTTTG 21 52 48
chCCLi3_probe CGCGGAACCTCATCCAGAGGCACTA 25 63 60
CXCLi2_forward GCCCTCCTCCTGGTTTCAG 19 55 63
CXCLi2_reverse TGGCACCGCAGCTCATT 17 50 59
CXCLi2_probe TCTTTACCAGCGTCCTACCTTGCGACA 27 61 52
IFNG_forward GTGAAGAAGGTGAAAGATATCATGGA 26 65 38
IFNG_reverse GCTTTGCGCTGGATTCTCA 19 51 53
IFNG_probe TGGCCAAGCTCCCGATGAACGA 22 59 59
IFNA_forward GACAGCCAACGCCAAAGC 18 63 51
IFNA_reverse GTCGCTGCTGTCCAAGCATT 20 54 55
IFNA_probe CTCAACCGGATCCACCGCTACACC 24 63 63
MMP9_forward CCAGCTACGATGCCGACAA 19 54 58
MMP9_reverse TCGCTGTTGCCACCATTG 18 50 56
MMP9_probe CTGCCCCAGCGAGCTGCTCTACA 23 62 65
MX1_forward TGGACTTCTGCAACGAATTGTC 22 53 45
MX1_reverse ATCCAGAAGAGTGCTGAAATGTTTG 25 54 40
MX1_probe TTCACCTCCGCAATCCAGCAAGAGA 25 59 52
IL6_forward GCTCGCCGGCTTCGA 15 50 73
IL6_reverse GGTAGGTCTGAAAGGCGAACAG 22 57 55
IL6_probe AGGAGAAATGCCTGACGAAGCTCTCCA 27 61 52
chCCLi4_forward CCCTCTCCATCCTCCTGGTT 20 56 60
chCCLi4_reverse TATCAGCCCCAAACGGAGAT 20 52 50
chCCLi4_probe CCGCCCTCTTCCCTCAAGCCTC 22 62 68
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expression postinfection. Probes for each of the viral genes
showed an increase in expression in the bursa at days 3 and 4 p.i. in
birds from the susceptible line (line 61) but was not seen in birds
from the resistant line (BrL), confirming the results shown in Fig.
1. No expression was detected in the spleen from either chicken
line (Table 2).
Host response to IBDV infection. After infection with virus,
no genes were seen to be significantly differentially expressed in
the resistant BrL birds. Gene expression differences between in-
fected and control birds of the susceptible line 61 at 2, 3, and 4 dpi
were therefore analyzed, with a view to examining the host innate
immune response to infection by IBDV. At day 2 there was an
initial response in the spleen (121 DE genes), although no gene
expression changes were noted in the bursa. It is not until day 3
that large gene expression changes were noted (1,228 DE genes in
the spleen and 3,069 DE genes in the bursa), which continued at
day 4 (826 DE genes in the spleen and 3,268 DE genes in the
bursa). A larger response was seen in the bursa than in the spleen,
which was expected, since the bursa is the main target organ for
the disease. Genes upregulated during the host response included
genes, e.g., IL-6, IL-8, MX1, IFIT5, TLR3, and NOS2A, that had
already been identified as being upregulated after IBDV infection
FIG 1 (A and B) Bursal load of IBDV (corrected 40-CT  the standard errors) (A) and bursal damage scores (B) at various times postinfection with virulent
(F52/70) IBDV. C control, uninfected; I infected; 6 resistant line 61 chickens; BrL susceptible Brown Leghorn chickens. n 9 birds per group per time
point.
FIG 2 (A and B)Histology staining with hematoxylin and eosin of the bursal damage seen at 2, 3, and 4 dpi in control and infected birds of line 61 (A) and Brown
Leghorn (B).
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FIG 3 Pathway Express analysis of the host response to IBDV infection in the spleen. Many genes in the apoptosis (A) and TLR pathways (B) are upregulated
(red). Genes in blue are downregulated.
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FIG 4 Pathway Express analysis of the host response to IBDV infection in the bursa. Many genes in the B cell receptor signaling pathway (A) are downregulated
(blue), as are many genes involved in the cell cycle (B).
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in previous studies. Many other genes with known immune func-
tion were involved in the response to IBDV, such as the matrix
metalloproteinsMMP9,MMP7,MMP1, andMMP3, the chemo-
kines CCLi7, CCLi4, CCL5, and CCL19, the interferon (IFN)-in-
duced transmembrane proteins IFITM1, IFITM3, and IFITM5, as
well as GBP, ART1, PDIP1, OASL, CSF3, IRF10, and TLR15, to
name but a few. Genes downregulated during the early host re-
sponse included BLVRA, MYBL1, AICDA, SFRP1, VPREB3,
SFTPA2, and TLR7. For a full list of the genes involved in both
bursa (3,658 DE probes) and spleen (1,476 DE probes) see Table
S1 in the supplemental material.
In order to confirm which biological processes were involved
during infection of the birds and to determine whether there was
any that had not been identified in previous, more-focused stud-
ies, we decided to analyze the gene ontology (GO) functional an-
notations of the genes being differentially expressed. Themicroar-
ray data produced for the host response (infected versus control
susceptible birds) in the spleen were analyzed with EasyGO (22),
which examines DE genes for their association with particular GO
terms compared to the microarray background as a whole. The
response in the spleenwas analyzed as opposed to that in the bursa
since the large degree of cell damage occurring in the bursa would
substantially mask the immune response. The genes differentially
expressed during this experiment were seen to be involved in
processes such as “immune response,” “apoptosis,” “response to
stimulus,” and “cytokine production,” which is what would be
expected in this type of infection.
The data were also analyzed using Pathway Express (23),
which, based upon the KEGGpathways (24), pictorially illustrates
the genes that are up- or downregulated in any given biological
pathway. Figure 3 shows examples using the data from the spleen
at 4 dpi. Genes involved in the extrinsic apoptosis pathway and the
Toll-like receptor signaling pathway, which play integral roles
during the innate immune response, are upregulated. In the bursa,
genes involved in the B-cell receptor signaling and cell cycle path-
ways were dramatically downregulated (Fig. 4). Many of the bio-
logical responses seen in the bursa will be due to viral replication
and cell damage and will not be antiviral responses per se. It must
be borne in mind that these diagrams are based on the human
pathways and so in some cases are not completely demonstrative
of the chicken pathways, i.e., avian-specific genes are not repre-
sented. Other pathways seen to be significantly (FDR-corrected P
value of0.25) involved are shown in Table 3.
In order to cluster the genes demonstrated to be involved in the
host response to IBDV into groups with similar expression pro-
files, the CLICK algorithmwithin the Expander program (25) was
used. The upregulated genes formed four distinct clusters, while
the downregulated genes all cluster together in a fifth group.
Expander was then also used to look for enrichment of GO
terms associated with genes, genomic locations and TFBS within
the clusteredDE genes (834 upregulated and 377 downregulated).
The upregulated genes were over-represented in biological pro-
cesses such as “immune response,” “response to stimulus,” “cyto-
kine activity,” and other functions associated with viral infection.
Only “protein binding” was highlighted among the downregu-
lated genes. Examination of the microarray data did not show any
TABLE 3 Pathway Express analysis of the host response to IBDV infection in the spleen
Rank Pathway Impact factor Input genes/genes in pathway Corrected gamma P value
1 Leukocyte transendothelial migration 41.149 12/119 5.68E–17
2 Cell adhesion molecules (CAMs) 30.238 14/134 2.30E–12
3 Phosphatidylinositol signaling system 23.129 1/76 2.18E–09
4 Cytokine-cytokine receptor interaction 17.66 39/263 3.99E–07
5 Circadian rhythm 12.371 1/13 5.67E–05
6 Jak/STAT signaling pathway 9.513 23/155 7.77E–04
7 Toll-like receptor signaling pathway 7.164 17/102 0.006318549
8 Graft-versus-host disease 6.712 4/42 0.00937956
9 Regulation of autophagy 6.442 1/35 0.011856721
10 Proteasome 6.319 1/48 0.013186967
11 TGF-	 signaling pathway 6.093 5/87 0.016020412
12 Complement and coagulation cascades 6.064 10/69 0.016424379
13 Neuroactive ligand-receptor interaction 4.986 14/256 0.040901989
14 Antigen processing and presentation 4.647 7/89 0.054156592
15 Axon guidance 4.491 14/129 0.061550973
16 Type I diabetes mellitus 4.456 3/44 0.063337096
17 Systemic lupus erythematosus 4.425 8/144 0.064960096
18 Allograft rejection 4.361 3/38 0.068436465
19 Epithelial cell signaling in Helicobacter pylori infection 4.348 12/68 0.069163823
20 Hematopoietic cell lineage 4.294 13/87 0.072264239
21 Type II diabetes mellitus 4.231 5/45 0.076047469
22 Apoptosis 4.198 13/89 0.078103058
23 Natural killer cell mediated cytotoxicity 4.168 10/135 0.080017155
24 Basal cell carcinoma 3.776 2/55 0.109438052
25 ABC transporters 3.54 7/44 0.131720505
26 Adipocytokine signaling pathway 3.205 7/67 0.170550181
27 Adherens junction 3.05 4/78 0.191803644
28 Renal cell carcinoma 2.845 10/69 0.223526256
29 Mitogen-activated protein signaling pathway 2.758 22/272 0.238326642
30 Long-term depression 2.695 6/75 0.249569101
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enrichment for a particular genomic location among the DE
genes. Upregulated genes showed an enrichment of TFBS for ISRE
(IFN stimulatory response element) and IRF7 (interferon regula-
tory factor 7). IRF7 regulates transcription of type I IFN genes and
IFN-stimulated genes by binding to ISRE motifs in their promot-
ers. Genes containing a binding site for the Drosophila transcrip-
tion factor Ovo (presumably the chicken orthologue thereof) was
also over-represented. No TFBS were seen to be enriched within
the downregulated array genes (Fig. 5).
Complementing the findings from Pathway Express, IPA was
also used to identify the physiological functions and biological
pathways most highly involved during the host response to IBDV
infection. The most significant physiological functions are repre-
sented in Fig. 6A. It can be clearly seen that processes involving B
and T cell development and differentiation constitutemany of the
pathways highlighted. Tissue development, necrosis, and mortal-
ity all seem to play an important role during IBDV infection. Path-
ways affected by IBDV infection are shown in Fig. 6B. Among the
upregulated genes, those involved in signaling from several cyto-
kine receptors (IFN, IL-6, IL-10, and GM-CSF/CSF-2), as well as
in apoptosis, were differentially expressed. Genes involved in the
activation of hepatic stellate cells were also differentially ex-
pressed. Interestingly, Ma et al. (26) recently described the effects
of IBDV on Kupffer cells, macrophages found in the lining of the
liver, suggesting that the liver is a site of IBDV infection and there-
fore possibly the innate immune response. Analysis of the down-
regulated genes highlights genes that are involved in endothelial
cell development, proliferation, and migration.
Differences between susceptible and resistant lines. Resis-
tance to IBD between the two lines could be due to a number of
mechanisms. For example, BrL birds could simply express certain
genes, such as those involved in key innate immune responses, at
a constitutively higher level than line 61 birds, and thus mount a
stronger innate response upon infection, limiting viral replication
and thus disease. Alternatively, after infection, BrL birds could
upregulate the expression of key immune function genes to a
greater degree than line 61 birds, thus mounting a stronger in-
duced immune response. Either or both mechanisms could con-
tribute to IBD resistance.
There were genes that showed large expression differences be-
tween the two lines, even before infection, which in turn led to the
differing responses seen upon infection. Examination of the con-
trol birds in the two lines showed considerable differences in ex-
pression levels of certain genes, including BLB1, SRFBP1,XRCC3,
TNFRSF1B, GNG4, and IFITM3, all of which were more highly
expressed in the resistant (BrL) than in the susceptible line (line
61). Some of these genes may therefore play an important role in
disease resistance (382DE probes in the spleen and 160DE probes
in the bursa: see Table S2 in the supplemental material).
Upon infection, differences in gene expression were also seen
between the two lines. Genes more highly expressed in the resis-
tant BrL line included BLB1, CARD9, BLVRA, AICDA, MYBL1,
SFRP1, B6.3, VPREB3 and MMP13, whereas genes more highly
expressed in the susceptible line included MMP9, IFNA, CCL5,
MMP7, AVD, NOS2A, CXCLi2, IL-6, LYG2, GBP, CCL19, IF-
ITM1, IFITM3, and IFITM5. Of course, “more highly expressed”
could also mean “less downregulated.” Again, it seems reasonable
to assume that some of these genes may play an important role in
resistance/susceptibility to IBDV. A full list of genes differentially
expressed between the two lines in both the bursa (3,659 DE
FIG 5 Over-representation analysis using the Expander program. (A) The GO
biological processes which are significantly enriched during the host response to
IBDV infection. The frequency of genes of a functional class within the examined
set is described as a percentage of the total. (B). Transcription factor binding sites
present in differentially expressed genes that are significantly overrepresented in
upregulatedgenesduring thehost response to IBDVinfection.The frequencyratio
(frequency of the set divided by the frequency of the background) is shown.
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probes) and the spleen (1,570 DE probes) is given in Table S3 in
the supplemental material.
Verification of the microarray results. Twenty-one genes
were chosen for verification by qRT-PCR, including genes in-
volved in the host response and genes differentially expressed be-
tween the susceptible and resistant lines (either inherently or dur-
ing the course of infection) (Table 4). Of the 20 genes tested,
differential expression in the microarray was confirmed in the
qRT-PCR analysis for 17. However, the microarray results for
SRFBP1, TNFRSF1B, and CARD9were not replicated in the qRT-
PCR analysis (note that the qRT-PCR assay did not work for
BLB1) (Fig. 7).
Potential candidate genes for IBDV resistance. In contrast to
other avian pathogens, very little information is available regard-
ing potential quantitative trait loci (QTL) regions for resistance to
IBDV. The only publishedmaterial is to be found in a Ph.D. thesis
(14) that suggests that several genomic regions are potentially in-
volved in resistance phenotypes, defined by death, bursal damage,
IBDV genomic RNA levels, and IFN-
mRNA levels.
Due to the lack of robust accompanying genetic data, we had to
identify potential candidate genes for resistance from our ex-
pression data alone. We found genes that are differentially ex-
pressed between susceptible and resistant lines either inher-
ently or in response to IBDV infection. Examination of these
genes, along with their known biology and how they might play
a role in the pathways and biological networks identified in our
analyses, allowed us to identify potential candidate genes for
susceptibility/resistance to IBDV infection. Table 4 lists candi-
date genes (indicated in boldface) for resistance to IBDV, as
determined by their differential expression between suscepti-
ble and resistant lines.
DISCUSSION
IBDVpreferentially replicates in IgMB cells, which it enters after
binding to cellular receptors, some of which have been identified,
and induces host cell apoptosis, with both VP2 and VP5 playing a
role in both binding and apoptosis. VP2 forms a subviral particle
which binds to HSP90 (27). Other host molecules, including p53
binding protein (TP53BP1), stathmin (STMN1), and chondroitin
sulfate, are also targets for VP2 (28). VP5 interacts with the volt-
FIG 6 IPA results for the host response to IBDV infection. (A) The most highly represented (P 0.05) physiological functions as revealed after IPA was used to
evaluate genes differentially expressed during the host response to IBDV (in the spleen). Specific functions within groups are highlighted. (B) The most highly
represented canonical pathways as revealed after IPAwas used to evaluate genes differentially expressed during the host response to IBDV (in the spleen). The line
represents the ratio of genes represented within each pathway.
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age-dependent anion channel 2 (VDAC2) protein (29) and with
the p85 regulatory subunit of phosphatidylinositol 3-kinase
(PI3K) (30). Integrin 4	1 is also a specific host binding receptor
for IBDV (31). Comparing gene expression levels between control
birds of each line, we found higher mRNA expression levels of
some of these receptor genes (HSPCB [HSP90B], TP53BP1,
STMN1, and ITGB1) in the resistant line (BrL) than in the suscep-
tible line (61). It seems counterintuitive that the resistant line
should havemore receptors for the virus than the susceptible line.
This presumably reflects some mechanism whereby viral entry
into the cell is limited. The Jun NH2-terminal kinase and p38
mitogen-activated kinase pathways (30, 32) have previously been
suggested to be involved in the pathogenesis of IBD. We confirm
here the involvement of these pathways during IBDV infection
and highlight the whole spectrum of genes in these pathways
whose expression is altered. The importance of apoptosis in IBD
pathogenesis is clear from the EasyGO analysis and Pathway Ex-
press highlights the affectedmolecules, also showing upregulation
of PI3K. IBDV activates PI3K/Akt signaling through binding of
the nonstructural VP5 protein to the p85 regulatory subunit of
PI3K, resulting in the suppression of premature apoptosis and
improved virus growth after infection (30). In the bursa, there is
also considerable downregulation of genes involved in the B
cell receptor signaling pathway and in the cell cycle. The former
probably reflects the huge reduction in B cell numbers as they
are destroyed by the infection. It remains to be seen whether
VP5, or indeed any of the other IBDV proteins, also targets the
cell cycle.
Generally, T cells are refractory to IBDV infection with IBDV
but promote virus clearance, by mechanisms that are not well
understood. Rauf et al. (33) showed that CD4 and CD8 T cells
enter the infected bursa and that cytotoxic T cells play a role in
clearing infected cells through the perforin-granzyme pathway,
as identified by the upregulation of mRNA expression levels for
perforin and granzyme, DNA repair and apoptotic proteins,
high-mobility protein group and poly(ADP-ribose) polymer-
ase (PARP) in the bursa, and the presence of perforin- and
granzyme-expressing CD8 T cells. Similarly in the present
study, we observed upregulation of granzyme A, various PARP
genes, and also IFN-
. Rauf et al. (33) also noted a decrease in
NK-lysin mRNA expression levels, suggesting a reduced role
for NK cells. In contrast, the present study demonstrated a
5-fold upregulation of NK lysin in the bursa at 3 dpi, rising to
15-fold at 4 dpi, suggesting that in these birds both cytotoxic T
cells and NK cells are involved in the response to the virus.
The chicken has a somewhat different repertoire of pattern
recognition receptors (PRR), including Toll-like receptors (TLR),
to that ofmammals (34), but the repertoire of potential pathogen-
associatedmolecular patterns (PAMP) recognized by these PRR is
thought to be similar. Little is understood of the effects infection
with different classes of pathogens have on the expression reper-
toire of the different TLR. In the present study, during the early
stages of IBDV infection in the bursa, mRNA expression levels of
TLR1LB, TLR2A, TLR3, TLR4, and TLR15 (and TLR21 in the
spleen) and the cytosolic PRR MDA5 were upregulated, whereas
those of TLR1LA, TLR2B, and TLR7 were downregulated. Other
studies have also reported this differential regulation of TLR3 and
TLR7 following infection with a classical strain of IBDV (33, 35).
TLR3 recognizes viral dsRNA, whereas TLR7 recognizes viral sin-
gle-stranded RNA; the genome of IBDV is dsRNA, and upregula-
tion of TLR3might represent a positive feedback loop to drive the
innate inflammatory antiviral response. MDA5 also recognizes
viral dsRNA, and its mRNA expression levels were also upregu-
lated (70-fold at 3 dpi compared to 9-fold for TLR3) in response to
IBDV infection.
It is more difficult to explain the differential mRNA expression
TABLE 4 Genes chosen for confirmation by qRT-PCR
Genea GenBank accession no. Description Fold changeb
BLB1 NM_001044694 MHC class II antigen B-F minor heavy chain 203–263*
SRFBP1 XM_424408 Serum response factor binding protein 1 24–25*
TNFRSF1B NM_204439 Tumor necrosis factor receptor superfamily, member 1B 8–9*
XRCC3 NM_001006489 X-ray repair complementing defective repair in Chinese
hamster cells 3
14–20*
AICDA XM_416483 Activation-induced cytidine deaminase 8–57†
B6.3 X92865 B cell marker chB6 (Bu-1) 6–42†
BLVRA XM_418872 Biliverdin reductase A 8–42†
CARD9 XM_425329 Caspase recruitment domain family, member 9 3–16†
MYBL1 NM_205232 Myeloblastosis oncogene-like 1 7–37†
TLR2B AB046533 Toll-like receptor 2, type 2 4–5†
CCL19 XM_424980 CCL19 homeostatic chemokine 84–99‡
CCLi3 NM_204720 CCLi3 MIP family chemokine 76–100‡
CCLi4 NM_001045832.1 CCL5 MIP family chemokine (RANTES) 209–318‡
CXCLi2 NM_205498 CXCLi2 (IL-8 homologue) 50–65‡
IFNA EU334503 IFN- 470–1,359‡
IFNB NM_001024836 IFN-	 51–85‡
IFNG NM_205149 IFN-
 32–72‡
IL13RA2 NM_001048078 IL-13 receptor-2 53–111‡
IL-6 NM_204628 IL-6 52–198‡
MMP9 NM_204667 Matrix metalloprotein 9 1,099–1,782‡
Mx1 NM_204609 Myxovirus resistance gene 1 60–69‡
a Genes indicated in boldface are potential candidate resistance genes.
b *, Inherently higher expression in the resistant line; †, higher expression in response to infection in the resistant than in thesusceptible line; ‡, upregulated in response to infection
in the susceptible line.
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patterns of some of the TLRs that are thought to generally recog-
nize components of the surface of pathogens, particularly bacte-
ria. The precise ligand of the chicken-unique TLR15 remains to be
determined. It has been described to recognize a variety of PAMP,
including diacylated lipopeptides (36) and a yeast-derived ag-
onist (37). We previously reported increased expression of
TLR15 after infection withMarek’s disease virus (38). Together
with the data presented in the present study, this implies a role
for TLR15 in antiviral responses and that it perhaps recognizes
a surface component of viruses. It is interesting to note the
differential response of the TLR1 and TLR2 paralogues, i.e.,
TLR1LB and TLR2A mRNA expression levels are upregulated,
and those of TLR2B and TLR1LA are downregulated. More-
over, TLR2-1 and TLR1-2 heterodimers cooperatively signal
the presence of PGN, diacylated lipopeptides and MALP-2,
whereas TLR2-1 and TLR1-1 heterodimers did not recognize
MALP-2. Both combinations, however, recognized the triacy-
lated lipopeptide, Pam3 (39). It is therefore clear that the two
different heterodimer combinations discriminate between dif-
ferent ligands and that they might differentially recognize sur-
face components of viruses.
Analysis of the samples from IBD-susceptible and -resistant
FIG 7 qRT-PCR analysis of 20 genes differentially expressed during IBDV infection. (A) Representative genes with inherent differences in expression between
susceptible and resistant control birds. (B) Representative genes with expression changes during the host response in the susceptible line. (C) Representative
genes with differential gene expression between the susceptible and resistant lines during the host response.
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birds, with or without infection with IBDV, using whole-genome
microarrays identified genes that either show different inherent
levels of gene expression (without infection) between the lines or
that are transcribed differently after infection, thus potentially
eliciting differing host responses. They are thus prime candidates
for future testing in genetic mapping studies, either as targets for
knockout experiments or as targets for direct interaction with
IBDV proteins.
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